A double-edged sword

Editorial

. 2008 Apr;7(4):275.

doi: 10.1038/nrd2562.

No authors listed

Editorial

No authors listed. Nat Rev Drug Discov. 2008 Apr.

. 2008 Apr;7(4):275.

doi: 10.1038/nrd2562.

No abstract available

Similar articles

Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz.
Rickels K, Robinson DS. Rickels K, et al. J Clin Psychopharmacol. 2009 Apr;29(2):197-8; author reply 198-9. doi: 10.1097/JCP.0b013e318199f275. J Clin Psychopharmacol. 2009. PMID: 19512995 No abstract available.
Factors contributing to failed trials of new agents: can technology prevent some problems?
Greist JH, Mundt JC, Kobak K. Greist JH, et al. J Clin Psychiatry. 2002;63 Suppl 2:8-13. J Clin Psychiatry. 2002. PMID: 15453008
Dosing strategies for antidepressant clinical trials: a commentary.
Robinson DS, Khan A. Robinson DS, et al. J Clin Psychopharmacol. 2004 Feb;24(1):1-3. doi: 10.1097/01.jcp.0000108980.47737.f8. J Clin Psychopharmacol. 2004. PMID: 14709939 No abstract available.
The mousetrap: managing the placebo effect in antidepressant trials.
Lakoff A. Lakoff A. Mol Interv. 2002 Apr;2(2):72-6. doi: 10.1124/mi.2.2.72. Mol Interv. 2002. PMID: 14993352 Review. No abstract available.
The new generation of antidepressants.
Feighner JP. Feighner JP. J Clin Psychiatry. 1983 May;44(5 Pt 2):49-55. J Clin Psychiatry. 1983. PMID: 6222037 Review. No abstract available.

Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers.
Eichler HG, Bloechl-Daum B, Abadie E, Barnett D, König F, Pearson S. Eichler HG, et al. Nat Rev Drug Discov. 2010 Apr;9(4):277-91. doi: 10.1038/nrd3079. Epub 2010 Feb 26. Nat Rev Drug Discov. 2010. PMID: 20186141 Review.
Challenging received wisdom: antidepressants and the placebo effect.
Kirsch I. Kirsch I. Mcgill J Med. 2008 Jul;11(2):219-22. Mcgill J Med. 2008. PMID: 19148327 Free PMC article.